India to Mauritius: Acarbose Export Trade Route
India has recorded 96 verified shipments of Acarbose exported to Mauritius, representing a combined trade value of $38.7K USD. This corridor is served by 7 active Indian exporters, with an average shipment value of $403 USD. The leading Indian exporter is HEXA HEALTHCARE PRIVATE LIMITED, which accounts for 38% of total export value with 4 shipments worth $14.8K USD. On the buying side, REGENCY PHARMA LIMITED is the largest importer in Mauritius with $37.0K USD in purchases. The top 3 suppliers — HEXA HEALTHCARE PRIVATE LIMITED, SAVA HEALTHCARE LIMITED, HEXA HEALTHCARE PVT LTD — together control 94% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Mauritius Acarbose corridor is one of India's established pharmaceutical export routes, with 96 shipments documented worth a combined $38.7K USD. The route is dominated by HEXA HEALTHCARE PRIVATE LIMITED, which alone accounts for roughly 38% of all export value, reflecting the consolidated nature of India's acarbose manufacturing sector.
Across 7 active suppliers, the average shipment value stands at $403 USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 82% of all shipments, consistent with acarbose's non-urgent bulk-order profile.
Shipment activity peaks during UNAVAILABLE, with an average transit time of 16 days port-to-port. The route has recorded an annual growth rate of 11.1%, placing it at rank #11 among India's top acarbose export destinations globally.
On the import side, key buyers of Indian acarbose in Mauritius include REGENCY PHARMA LIMITED, REGENCY PHARMA LTD, REGENCY PHARMA LIMITED and 1 others. REGENCY PHARMA LIMITED is the single largest importer with 85 shipments valued at $37.0K USD.
